Related pages Drug Information Summaries Approval Process for New Cancer Treatments Access to Investigational Drugs: Q & A

This page contains brief information about aprepitant and a collection of links to more information from the National Cancer Institute (NCI), the Food and Drug Administration (FDA), and the National Library of Medicine (NLM).

US Brand Name(s):		Emend
FDA Approved:		Yes

Aprepitant is approved by the Food and Drug Administration (FDA) to be used together with other drugs to prevent and control nausea and vomiting caused by chemotherapy. It is also used by itself to prevent nausea and vomiting after surgery.

FDA Patient Information Information Sheet on Aprepitant - A lay language summary of important information about this drug that may include the following:

• FDA warnings or alerts about this drug,
• what this drug is used for and how it is used,
• what you should tell your doctor before using this drug,
• what you should know about this drug before using it,
• other drugs that may interact with this drug, and
• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This FDA patient information sheet applies only to approved uses of the medicine. However, much of the information may also apply to unapproved uses that are being studied.

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Clinical Trial Results: Aprepitant Reduces Chemotherapy-Induced Vomiting (05/06/2005) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Aprepitant Improves Antinausea Medications (10/28/2003) - Important clinical trial results for this drug, background information, and how the trial was done.

MedlinePlus Information on Aprepitant - A lay language summary of important information about this drug that may include the following:

• warnings about this drug,
• what this drug is used for and how it is used,
• what you should tell your doctor before using this drug,
• what you should know about this drug before using it,
• other drugs that may interact with this drug, and
• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This NLM patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials for Aprepitant - Check for trials from NCI's PDQ Cancer Clinical Trials Registry now accepting patients.

Back to Top